Adverse event totals15

The totals the trial posted for each group.

1 to 15 of 15

Total	Group	Affected	At risk
Total, all-cause mortality	CAM-3001 10 MG
Total, all-cause mortality	CAM-3001 30 MG
Total, all-cause mortality	CAM-3001 50 MG
Total, all-cause mortality	CAM-3001 100 MG
Total, all-cause mortality	PLACEBO
Total, other adverse events	CAM-3001 10 MG	32	48
Total, other adverse events	CAM-3001 30 MG	29	49
Total, other adverse events	CAM-3001 50 MG	26	49
Total, other adverse events	CAM-3001 100 MG	28	48
Total, other adverse events	PLACEBO	46	96
Total, serious adverse events	CAM-3001 10 MG	2	48
Total, serious adverse events	CAM-3001 30 MG	2	49
Total, serious adverse events	CAM-3001 50 MG	1	49
Total, serious adverse events	CAM-3001 100 MG	0	48
Total, serious adverse events	PLACEBO	1	96

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01050998/event-totals